BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15177503)

  • 1. Disturbed melanin synthesis and chronic oxidative stress in dysplastic naevi.
    Pavel S; van Nieuwpoort F; van der Meulen H; Out C; Pizinger K; Cetkovská P; Smit NP; Koerten HK
    Eur J Cancer; 2004 Jun; 40(9):1423-30. PubMed ID: 15177503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased melanogenesis is a risk factor for oxidative DNA damage--study on cultured melanocytes and atypical nevus cells.
    Smit NP; van Nieuwpoort FA; Marrot L; Out C; Poorthuis B; van Pelt H; Meunier JR; Pavel S
    Photochem Photobiol; 2008; 84(3):550-5. PubMed ID: 18435613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micro-anatomy related antigen expression in melanocytic lesions.
    Meije CB; Mooi WJ; Le Poole IC; Van Muijen GN; Das PK
    J Pathol; 2000 Apr; 190(5):572-8. PubMed ID: 10727983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of the water-soluble polymer-wrapped derivative of fullerene on UVA-induced melanogenesis via downregulation of tyrosinase expression in human melanocytes and skin tissues.
    Xiao L; Matsubayashi K; Miwa N
    Arch Dermatol Res; 2007 Aug; 299(5-6):245-57. PubMed ID: 17333222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of vascular endothelial growth factor in early cutaneous melanocytic lesion progression.
    Einspahr JG; Thomas TL; Saboda K; Nickolof BJ; Warneke J; Curiel-Lewandrowski C; Ranger-Moore J; Duckett L; Bangert J; Fruehauf JP; Alberts DS
    Cancer; 2007 Dec; 110(11):2519-27. PubMed ID: 17932890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common and dysplastic naevi as risk factors for cutaneous malignant melanoma in a Swedish population.
    Augustsson A; Stierner U; Rosdahl I; Suurküla M
    Acta Derm Venereol; 1991; 71(6):518-24. PubMed ID: 1685835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS; Shakhtour B; Shyr Y
    J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of melanogenesis and morphogenesis of melanosomes by physicochemical properties of melanin and melanosomes in malignant melanoma.
    Jimbow K; Miyake Y; Homma K; Yasuda K; Izumi Y; Tsutsumi A; Ito S
    Cancer Res; 1984 Mar; 44(3):1128-34. PubMed ID: 6318981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of microtubule-associated protein 2 in melanocytic skin lesions.
    Gambichler T; Rotterdam S; Radkowski K; Altmeyer P; Kreuter A
    Am J Clin Pathol; 2009 May; 131(5):710-4. PubMed ID: 19369632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk factors for skin melanoma: genetic factors probably more important than exposure to sunlight].
    Pavel S; Smit NP
    Ned Tijdschr Geneeskd; 2004 Nov; 148(46):2267-72. PubMed ID: 15584541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [From dysplastic nevus to malignant melanoma--a study of 4 anatomoclinical cases of dysplastic nevus syndrome].
    Huynh Do P; Joris F
    Praxis (Bern 1994); 1997 Nov; 86(47):1854-9. PubMed ID: 9480503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactive oxygen species in melanoma and its therapeutic implications.
    Wittgen HG; van Kempen LC
    Melanoma Res; 2007 Dec; 17(6):400-9. PubMed ID: 17992124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma associated with a dysplastic nevus: report of two cases with unusual sebocyte-like melanocytes in the nevus part of the lesion.
    Vazmitel M; Michal M; Mukensnabl P; Kazakov DV
    Am J Dermatopathol; 2007 Dec; 29(6):566-7. PubMed ID: 18032954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dysplastic nevus syndrome].
    Niebauer G; Kokoschka EM
    Wien Klin Wochenschr; 1986 Oct; 98(20):673-8. PubMed ID: 3788185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of claudin-1 expression in tumor-associated vessels correlates with acquisition of metastatic phenotype in melanocytic neoplasms.
    Cohn ML; Goncharuk VN; Diwan AH; Zhang PS; Shen SS; Prieto VG
    J Cutan Pathol; 2005 Sep; 32(8):533-6. PubMed ID: 16115050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoplasmic beta-catenin is lacking in a subset of melanoma-associated naevi, but is detectable in naevus-associated melanomas: potential implications for melanoma tumorigenesis?
    De Panfilis G; Ferrari D; Santoro S; Ricci R; Lombardi M; Pedrazzi G; Pepe C; Cortelazzi C; Santini M
    Br J Dermatol; 2009 Mar; 160(3):600-8. PubMed ID: 19183173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine structure and x-ray microanalysis of melanosomes in pigmented nevi and melanomas.
    Szekeres L
    Arch Dermatol Forsch; 1975 Jul; 252(4):297-304. PubMed ID: 1164039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma versus dysplastic naevi: microtopographic skin study with noninvasive method.
    Mazzarello V; Soggiu D; Masia DR; Ena P; Rubino C
    J Plast Reconstr Aesthet Surg; 2006; 59(7):700-5. PubMed ID: 16782565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The stepwise two-photon excited melanin fluorescence is a unique diagnostic tool for the detection of malignant transformation in melanocytes.
    Leupold D; Scholz M; Stankovic G; Reda J; Buder S; Eichhorn R; Wessler G; Stücker M; Hoffmann K; Bauer J; Garbe C
    Pigment Cell Melanoma Res; 2011 Jun; 24(3):438-45. PubMed ID: 21457482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between melanogenic and catalase activity in in vitro human melanocytes: a synergic strategy against oxidative stress.
    Maresca V; Flori E; Briganti S; Mastrofrancesco A; Fabbri C; Mileo AM; Paggi MG; Picardo M
    Pigment Cell Melanoma Res; 2008 Apr; 21(2):200-5. PubMed ID: 18426413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.